At a glance
ClinicalIndex Comparison RecordN/ACompleted· 402 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Non Interventional Study Evaluating Efficacy and Safety in a Cohort of Elderly Patients of First Line Therapy With Avastin ® Regimen for Metastatic Colorectal Cancer.
In Brief
An observational study for Colorectal Cancer. Completed, enrolled 402 participants across 166 sites.
Detailed Summary
This multicenter, prospective, observational study will evaluate the efficacy and safety of Avastin (bevacizumab) in first-line therapy in elderly patients with metastatic colorectal cancer. Data will be collected from eligible patients for24 months.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsColorectal Cancer
CountriesFrance
Collaborators--
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartMar 2012
First PostedMar 2012
Primary CompletionJul 2016
TodayJul 2026
First PostedMar 15, 2012
Enrollment StartMar 5, 2012
Primary CompletionJul 20, 2016
TodayJul 2, 2026
Enrollment to primary: 4.4 yearsPosted 14.3 years ago